Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Radius Health, Inc. (NASDAQ: RDUS).

Full DD Report for RDUS

You must become a subscriber to view this report.


Recent News from (NASDAQ: RDUS)

Radius Health Appoints Dr. Charles Morris as Chief Medical Officer
WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) today announced the appointment of Dr. Charles Morris as Chief Medical Officer. Dr. Morris will oversee and lead all clinical development, regulatory and medical affairs strateg...
Source: GlobeNewswire
Date: September, 04 2018 09:15
BioXcel Therapeutics Appoints Dr. David C. Hanley as Vice President and Head of Global Pharmaceutical Development and Operations
BRANFORD, Conn., Sept. 04, 2018 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq: BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology,...
Source: GlobeNewswire
Date: September, 04 2018 08:00
Closing Out My Radius Health Short With Lessons Learned
I’ve recently closed out my Radius Health ( RDUS ) short position which I initiated in December of 2014 at a price of about $37. Though the trade was profitable (I closed out at around $20.50), it wasn’t really successful. In this article I’d like to dissect the trade, inc...
Source: SeekingAlpha
Date: August, 24 2018 08:22
Radius Health, Inc. (RDUS) CEO Jesper Høiland on Q2 2018 Results - Earnings Call Transcript
Radius Health, Inc. (RDUS) Q2 2018 Earnings Conference Call August 7, 2018 8:00 AM ET Executives Elhan Webb - Head of Investor Relations and External Communications Jesper Høiland - President and Chief Executive Officer Jose Carmona - Senior Vice President and Chief Financia...
Source: SeekingAlpha
Date: August, 07 2018 14:23
Radius Health, Inc. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Radius Health, Inc. in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: August, 07 2018 08:09
Radius Health beats by $0.36, beats on revenue
Radius Health (NASDAQ: RDUS ): Q2 EPS of -$0.99 beats by $0.36 . More news on: Radius Health, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 07 2018 07:47
Radius Health Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update
Second quarter 2018 TYMLOS sales increase to $22.6 million, a 56% increase  over the first quarter of 2018 TYMLOS’ share in the U.S. anabolic osteoporosis market increased to an average of 19% in the second quarter from 13% in the prior quarter Radius maintains its 19-...
Source: GlobeNewswire
Date: August, 07 2018 07:45
Notable earnings before Tuesday's open
ACM , AES , AFI , AMRC , ANIP , AQUA , ARMK , ATKR , AVNS , AYR , BHC , BIOS , BLD , BOLD , BR , CEVA , CORE , CROX , DEA , DF , DISCA , DNR , DQ , EGN , EGRX , EMR , EPC , EXPD , FSS , GSKY , GTN , HAE , HLNE , IIVI , IONS , JELD , LABL , LGIH , LPX ,...
Source: SeekingAlpha
Date: August, 06 2018 17:30
New Research Coverage Highlights Ladder Capital, Gibraltar Industries, Norwegian Cruise Line, Wolverine World Wide, Catalyst Pharmaceuticals, and Radius Health - Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ladder Capital Corp (NYSE:LADR), Gibraltar Industries, Inc. (NASDAQ:ROCK)...
Source: GlobeNewswire
Date: August, 01 2018 07:30
Free Technical Reports on Sarepta Therapeutics and Three Additional Biotech Equities
Stock Research Monitor: PLX, RDUS, and RIGL LONDON, UK / ACCESSWIRE / July 31, 2018/ If you want a free Stock Review on SRPT sign up now at www.wallstequities.com/registration . On Monday, the NASDAQ Composite ended the day at 7,630.00, down 1.39%; the Dow Jones Industrial Average edg...
Source: ACCESSWIRE IA
Date: July, 31 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0819.0718.6419.2318.58562,122
2018-05-2131.4829.0131.6528.691,005,811
2018-05-1831.8831.3932.0931.32521,315
2018-05-1732.2131.7332.2731.29762,209
2018-05-1632.7832.1932.7831.89815,516

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1048,68985,15557.1769Short
2018-12-0752,15884,03962.0640Short
2018-12-0647,870153,06031.2753Cover
2018-12-0474,591179,44041.5688Short
2018-12-0349,67389,93455.2327Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on RDUS.


About Radius Health, Inc. (NASDAQ: RDUS)

Logo for Radius Health, Inc. (NASDAQ: RDUS)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $1,473,551,047 - 05/11/2018
  • Issue and Outstanding: 45,076,508 - 02/26/2018

 


Recent Filings from (NASDAQ: RDUS)

Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 20 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 01 2018

 

 


Daily Technical Chart for (NASDAQ: RDUS)

Daily Technical Chart for (NASDAQ: RDUS)


Stay tuned for daily updates and more on (NASDAQ: RDUS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: RDUS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in RDUS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of RDUS and does not buy, sell, or trade any shares of RDUS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/